# OnCo record nct07172919 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07172919/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07172919", "NCT07172919" ;
  schema:name "A Rollover Study Evaluating Sotorasib With or Without Panitumumab in Participants With KRAS p.G12C Mutation"@en ;
  schema:description "A phase 2 trial of Sotorasib and Panitumumab in advanced solid tumours, run by Amgen, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07172919/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07172919> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2026-01-02" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:technologies <https://onco.cc/technologies/kras-inhibitors/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:drugs <https://onco.cc/drugs/sotorasib/>, <https://onco.cc/drugs/panitumumab/> ;
  onco:companies <https://onco.cc/companies/amgen/> .
